Key result
ESCAPE trial tests blended collaborative care to improve quality of life in multimorbid heart failure.
Why the study?
Multimorbidity treatment is an increasing challenge for healthcare systems in ageing societies, prompting the evaluation of an integrated biopsychosocial care model for multimorbid elderly patients.
Does a 9-month blended collaborative care intervention improve health-related quality of life in older multimorbid heart failure patients compared to usual care?
Does a 9-month blended collaborative care intervention improve health-related quality of life in older multimorbid heart failure patients compared to usual care?
The ESCAPE trial protocol outlines a blended collaborative care intervention aimed at improving health-related quality of life in older, multimorbid heart failure patients with psychological distress.
Planned RCT needed to test blended collaborative care on QoL in multimorbid HF; leaves open current practice implications.
ESCAPE: Evaluation of a patient-centred biopsychosocial blended collaborative care pathway for the treatment of multimorbid elderly patients. THERAPEUTIC AREA: Healthcare interventions for the management of older patients with multiple morbidities. AIMS: Multi-morbidity treatment is an increasing challenge for healthcare systems in ageing societies. This comprehensive cohort study with embedded randomized controlled trial tests an integrated biopsychosocial care model for multimorbid elderly patients. HYPOTHESIS: A holistic, patient-centred pro-active 9-month intervention based on the blended collaborative care (BCC) approach and enhanced by information and communication technologies can improve health-related quality of life (HRQoL) and disease outcomes as compared with usual care at 9 months. METHODS: Across six European countries, ESCAPE is recruiting patients with heart failure, mental distress/disorder plus ≥2 medical co-morbidities into an observational cohort study. Within the cohort study, 300 patients will be included in a randomized controlled assessor-blinded two-arm parallel group interventional clinical trial (RCT). In the intervention, trained care managers (CMs) regularly support patients and informal carers in managing their multiple health problems. Supervised by a clinical specialist team, CMs remotely support patients in implementing the treatment plan-customized to the patients' individual needs and preferences-into their daily lives and liaise with patients' healthcare providers. An eHealth platform with an integrated patient registry guides the intervention and helps to empower patients and informal carers. HRQoL measured with the EQ-5D-5L as primary endpoint, and secondary outcomes, that is, medical and patient-reported outcomes, healthcare costs, cost-effectiveness, and informal carer burden, will be assessed at 9 and ≥18 months. CONCLUSIONS: If proven effective, the ESCAPE BCC intervention can be implemented in routine care for older patients with multiple morbidities across the participating countries and beyond.
No takes yet. Share an insight, caveat, or question.
Zelenak et al. (2023) studied Heart failure with somatic-mental multi-morbidity (n=450). Blended collaborative care (BCC) intervention vs. Usual care was evaluated on Health-related quality of life (HRQoL) measured with the EQ-5D-5L index at 9 months. The ESCAPE blended collaborative care intervention will be evaluated in a randomized controlled trial of 300 older multimorbid patients with heart failure to determine its effect on health-related quality of life compared to usual care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: